Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
FEBS Letters|November 2, 1987
The preparation and properties of novel reversible polymer-protein conjugates. 2-omega-Methoxypolyethylene (5000) glycoxymethylene-3-methylmaleyl conjugates of plasminogen activatorsA J Garman, S B Kalindjian
The Biochemical Journal|December 1, 1987
Reagents for reversible coupling of proteins to the active centres of trypsin-like serine proteinasesS B Kalindjian, R A Smith
British Journal of Pharmacology|June 27, 2007
Thermodynamic analysis of ligands at cholecystokinin CCK2 receptors in rat cerebral cortexE A Harper, S P Roberts, S B Kalindjian
British Journal of Pharmacology|November 25, 2010
Principles of early drug discoveryJ P Hughes, S Rees, S B Kalindjian, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
From histamine to imidazolylalkyl-sulfonamides: the design of a novel series of histamine H3-receptor antagonistsM J Tozer, E A Harper, S B Kalindjian, et al.
British Journal of Clinical Pharmacology|October 21, 2006
Unexpected relationship between plasma protein binding and the pharmacodynamics of 2-NAP, a CCK1-receptor antagonistV P Gerskowitch, J Hodge, R A D Hull, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 1999
4-Chlorobenzyl sulfonamide and sulfamide derivatives of histamine homologues: the design of potent histamine H3 receptor antagonistsM J Tozer, I M Buck, T Cooke, et al.
The European Journal of Neuroscience|October 19, 2010
Retinoic acid receptor-α signalling antagonizes both intracellular and extracellular amyloid-β production and prevents neuronal cell death caused by amyloid-βC I Jarvis, M B Goncalves, E Clarke, et al.
Thrombosis and Haemostasis|December 20, 1993
The use of active centre acylation to control the pharmacokinetic profile of a recombinant chimaeric plasminogen activatorS Wilson, D W Cronk, I Dodd, et al.
Journal of Medicinal Chemistry|July 6, 2000
Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H(3) receptor antagonistsI D Linney, I M Buck, E A Harper, et al.
Pageof 2